Kunin Audrey 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Dec 7, 2021
Insider Transaction Report
Form 4
Kunin Audrey
Chief Product Officer
Transactions
- Purchase
Common Stock
2021-12-03$0.46/sh+101,650$47,013→ 500,000 total(indirect: See footnote)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $0.4600 to $0.4650. The price reported above reflected the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.